About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Smith and Nephew’s Wound Therapy System

by Kathy Jones on January 9, 2012 at 9:15 PM
Font : A-A+

 FDA Approves Smith and Nephew’s Wound Therapy System

London based medical devices company Smith and Nephew revealed that its single use Negative Pressure Wound Therapy (NPWT) system, PICO has been approved by the US Food and Drug Administration to be used in both hospital and homecare settings.

The pocket sized device has already been approved in Canada, Europe and Australia and the FDA's approval means that NPWT will now be an option for patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures.

Advertisement

Stating that PICO was the perfect example of the company's commitment towards innovation, Smith & Nephew Advanced Wound Management president, Thomas Dugan said, "We are the first company to deliver effective, single use, disposable NPWT using the combination of a small, portable pump and advanced dressing technology. The PICO system demonstrates our commitment to innovation and reinforces our pledge to help reduce the human and economic cost of wounds."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Reiki and Pranic Healing Keloids 

Most Popular on Medindia

Nutam (400mg) (Piracetam) Pregnancy Confirmation Calculator Hearing Loss Calculator Diaphragmatic Hernia Calculate Ideal Weight for Infants Indian Medical Journals Drug Interaction Checker Loram (2 mg) (Lorazepam) Drug - Food Interactions Find a Doctor
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use